The role of utrophin in the potential therapy of Duchenne muscular dystrophy
The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abstract
Duchenne muscular dystrophy is an X-linked recessive muscle wasting disease caused by the absence of the muscle cytoskeletal protein, dystrophin. Dystrophin is a member of the spectrin superfamily of proteins and is closely related in sequence similarity and functional motifs to three proteins that constitute the dystrophin related protein family, including the autosomal homologue, utrophin. An alternative strategy circumventing many problems associated with somatic gene therapies for Duchenne muscular dystrophy has arisen from the demonstration that utrophin can functionally substitute for dystrophin and its over-expression in muscles of dystrophin-null transgenic mice completely prevents the phenotype arising from dystrophin deficiency. One potential approach to increase utrophin levels in muscle for possible therapeutic purpose in humans is to increase expression of the utrophin gene at a transcriptional level via promoter activation. This has lead to an interest in the identification and manipulation of important regulatory regions and/or molecules that increase the expression of utrophin and their delivery to dystrophin-deficient tissue. As pre-existing cellular mechanisms are utilized, this approach would avoid many problems associated with conventional gene therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Expression of a single transfected cDNA converts fibroblasts to myoblasts
Davis, R. L., Weintraub, H., & Lassar, A. B. (1987) · Cell · doi:10.1016/0092-8674(87)90585-x · Cited by 3,385
Koenig, M., Hoffman, E. P., Bertelson, C. J., Monaco, A. P., Feener, C., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90504-6 · Cited by 2,411
Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD
Wright, W. E., Sassoon, D. A., & Lin, V. K. (1989) · Cell · doi:10.1016/0092-8674(89)90583-7 · Cited by 1,266
Edmondson, D. G., & Olson, E. N. (1989) · Genes & Development · doi:10.1101/gad.3.5.628 · Cited by 841
Synaptic structure and development: The neuromuscular junction
Hall, Z. W., & Sanes, J. R. (1993) · Cell · doi:10.1016/s0092-8674(05)80031-5 · Cited by 834
Lassar, A. B., Buskin, J. N., Lockshon, D., Davis, R. L., Apone, S., Hauschka, S. D., & Weintraub, H. (1989) · Cell · doi:10.1016/0092-8674(89)90935-5 · Cited by 818
Identification of MRF4: a new member of the muscle regulatory factor gene family.
Rhodes, S. J., & Konieczny, S. F. (1989) · Genes & Development · doi:10.1101/gad.3.12b.2050 · Cited by 757
Utrophin–dystrophin-deficient mice as a model for Duchenne muscular dystrophy
Deconinck, A. E., Rafael, J. A., Skinner, J. A., Brown, S. C., Potter, A. C., Metzinger, L., Watt, D. J., Dickson, J. G., Tinsley, J. M., & Davies, K. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80532-2 · Cited by 752
Self-citationThe structural and functional diversity of dystrophin
Ahn, A. H., & Kunkel, L. M. (1993) · Nature Genetics · doi:10.1038/ng0493-283 · Cited by 650
Research works printed but not linked: 1
- Tinsley, 1998, Expression of full-length utrophin prevents muscular dystrophy in mdx mice, Nat Med, 4, 1441, 10.1038/4033 · DOI · Paper page
Cited by
Nowak, K. J., & Davies, K. E. (2004) · EMBO reports · doi:10.1038/sj.embor.7400221 · Cited by 357
“Upregulation of utrophin, an autosomal paralogue of dystrophin, has been proposed as a potential therapy for DMD (Perkins & Davies, 2002; Khurana & Davies, 2003).”
BackgroundSelf-citationPujol, A., Ferrer, I., Camps, C., Metzger, E., Hindelang, C., Callizot, N., Ruiz, M., Pàmpols, T., Giròs, M., & Mandel, J. L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh323 · Cited by 201
“Well-known examples for such approaches include the compensatory drug-mediated induction of fetal haemoglobin in b-globin disorders (7,8), the upregulation of utrophin in the dystrophin-deficient muscles of Duchenne’s muscular dystrophy (9,10) or very recently, the stimulation of SMN2 transcription by valproic acid as…”
BackgroundThe role of corticosteroids in muscular dystrophy: A critical appraisal
Angelini, C. (2007) · Muscle & Nerve · doi:10.1002/mus.20812 · Cited by 191
Ljubicic, V., Miura, P., Burt, M., Boudreault, L., Khogali, S., Lunde, J. A., Renaud, J.-M., & Jasmin, B. J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr265 · Cited by 162
“Utrophin may be able to serve as a surrogate for dystrophin in DMD muscle fibers because there is convincing evidence for functional redundancy between these two proteins (12,13).”
BackgroundThe zebrafish as a model for muscular dystrophy and congenital myopathy
Bassett, D. I., & Currie, P. D. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg279 · Cited by 156
“This last observation has lead to attempts to identify ways to increase utrophin production in the hope of allowing a therapeutic level of compensation (23).”
Background
Metadata
- Authors
- Perkins, K. J., & Davies, K. E.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Davies, Kay E
- ORCID
- Davies, Kay E
- Venue
- Neuromuscular Disorders
- Publisher
- Elsevier BV
- Published
- 2002-10
- Volume
- 12
- Pages
- S78-S89
- ISSN
- 0960-8966 (ISSN-L)
- OpenAlex
- W1966945158
- Cited by
- 71
- References
- 120
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 4 · 2013: 3 · 2012: 2
- FWCI
- 0.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Neuromuscular Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- utrophin, Duchenne muscular dystrophy, dystrophin, dystrophin-related protein, promoter activation, transcriptional regulation, muscle atrophy
- MeSH terms
- Animals, Cytoskeletal Proteins, Humans, Membrane Proteins, Muscular Dystrophy, Animal, Promoter Regions, Genetic, Genetic Therapy, Up-Regulation, Dystrophin, Mice, Inbred mdx, Muscular Dystrophy, Duchenne, Utrophin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of utrophin in the potential therapy of Duchenne muscular dystrophy. https://app.cochat.ai/papers/10.1016/s0960-8966(02)00087-1
- The paper
- Perkins, K. J., & Davies, K. E. (2002). The role of utrophin in the potential therapy of Duchenne muscular dystrophy. Neuromuscular Disorders. https://doi.org/10.1016/s0960-8966(02)00087-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.